Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 7 Glioblastoma 6 Squamous Cell Carcinoma of Head and Neck 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Gliosarcoma 5 Polycythemia Vera 4 Meningioma 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Neoplasms 3 Leukemia 3 Laryngeal Neoplasms 3 Glioma 3 Thrombocythemia, Essential 2 Primary Myelofibrosis 2 Pharyngeal Neoplasms 2 Paranasal Sinus Neoplasms 2 Myelodysplastic Syndromes 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Squamous Cell 2 Tongue Neoplasms 1 Thrombosis 1 Thrombocytosis 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Polycythemia 1 Papillomavirus Infections 1

Interventions

Uterine Myomectomy 1 Triamcinolone Acetonide 1 Sodium Chloride 1 Imatinib Mesylate 1 Hydroxyurea 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fibroma × Hydroxyurea × Clear all

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡